Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 623

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular Hypertrophy: The 4E–Left Ventricular Hypertrophy Study

Open access
Pitt, Bertram, Reichek, Nathaniel, Willenbrock, Roland, Zannad, Faiez, Phillips, Robert A., Roniker, Barbara, Kleiman, Jay, Krause, Scott, Burns, Daniel, Williams, Gordon H.·2003·Circulation

Abstract

Background— Elevated renin-angiotensin-aldosterone system activity correlates with left ventricular hypertrophy (LVH) and cardiovascular risk, but the relative contributions of angiotensin II and aldosterone remain unclear. This study compared LVH regression during treatment with the selective aldosterone blocker eplerenone, enalapril, and their combination in patients with hypertension. Methods and Results— A 9-month, double-blind, randomized study was performed in 202 patients with LVH and hypertension who received eplerenone 200 mg daily, enalapril 40 mg daily, or eplerenone 200 mg and enalapril 10 mg daily. At week 8, hydrochlorothiazide 12.5 to 25 mg and/or amlodipine 10 mg was added if diastolic blood pressure was >90 mm Hg. Change in left ventricular (LV) mass as assessed by MRI was the primary end point. Change in blood pressure, renin-angiotensin-aldosterone system hormones, albuminuria, and safety were also assessed. Eplerenone significantly reduced LV mass from baseline (−14.5±3.36 g; n=50) similarly to enalapril (−19.7±3.20 g; n=54; P =0.258), but eplerenone/enalapril (−27.2±3.39 g; n=49) was more effective than eplerenone alone ( P =0.007). All treatments reduced systolic blood pressure and diastolic blood pressure from baseline (eplerenone, −23.8 and −11.9 mm Hg; enalapril, −24.7 and −13.4 mm Hg; and eplerenone/enalapril, −28.7 and −14.4 mm Hg, P =0.048, in systolic blood pressure compared with eplerenone alone). Cough was more common with enalapril than with eplerenone ( P =0.033), and elevated potassium was more common with eplerenone. Conclusions— Eplerenone was as effective as enalapril in LVH regression and blood pressure control. The combination of eplerenone and enalapril was more effective in reducing LV mass and systolic blood pressure than eplerenone alone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000091405.00772.6e

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 623

Metadata

Authors
Pitt, B., Reichek, N., Willenbrock, R., Zannad, F., Phillips, R. A., Roniker, B., Kleiman, J., Krause, S., Burns, D., & Williams, G. H.
Venue
Circulation
Published
2003-10-14
Volume
108
Issue
15
Pages
1831-1838
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2170880252
Cited by
623
References
26
FWCI
27.57
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular Hypertrophy: The 4E–Left Ventricular Hypertrophy Study. https://app.cochat.ai/papers/10.1161/01.cir.0000091405.00772.6e
The paper
Pitt, B., Reichek, N., Willenbrock, R., Zannad, F., Phillips, R. A., Roniker, B., Kleiman, J., Krause, S., Burns, D., & Williams, G. H. (2003). Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular Hypertrophy: The 4E–Left Ventricular Hypertrophy Study. Circulation. https://doi.org/10.1161/01.cir.0000091405.00772.6e

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.